Sign In
Buy ACHV
$4.92
-0.110 (-2.19%)
At Close: Jun 03, 2026
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week
04:11pm, Wednesday, 17'th Dec 2025
SEATTLE and VANCOUVER, BC , Dec. 17, 2025 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercializat
Achieve Life Sciences (NASDAQ:ACHV) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened
04:02am, Friday, 12'th Dec 2025
Achieve Life Sciences, Inc. (NASDAQ: ACHV - Get Free Report) shares passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $3.44
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
04:10pm, Monday, 08'th Dec 2025
SEATTLE and VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development a
Head-To-Head Survey: Achieve Life Sciences (NASDAQ:ACHV) vs. Carisma Therapeutics (NASDAQ:CARM)
02:24am, Sunday, 23'rd Nov 2025
Carisma Therapeutics (NASDAQ: CARM - Get Free Report) and Achieve Life Sciences (NASDAQ: ACHV - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare th
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving Average – Here’s Why
03:56am, Thursday, 20'th Nov 2025
Achieve Life Sciences, Inc. (NASDAQ: ACHV - Get Free Report) crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $3.24 and traded as high as
Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call Transcript
03:26pm, Thursday, 06'th Nov 2025
Achieve Life Sciences, Inc. ( ACHV ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Nicole Jones Richard A. Stewart - CEO & Executive Director Jaime Xinos - Chief Commercial O
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
07:00am, Thursday, 06'th Nov 2025
One of Only Nine Therapies Chosen for the Inaugural FDA Commissioner's National Priority Voucher for E-cigarette or Vaping Cessation Conference Call Scheduled for 8:30 AM EST Today, November 6, 2025
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
08:30am, Monday, 03'rd Nov 2025
120-Day Safety Update Submitted to FDA ORCA-OL Long-Term Safety Trial Successfully Concluded DSMC Completes Final Review of Cytisinicline, Finds No Drug Safety Concerns
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025
08:30am, Wednesday, 29'th Oct 2025
SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development a
Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
08:30am, Monday, 20'th Oct 2025
New life sciences executive brings more than 25 years of legal expertise spanning clinical and commercial stage biopharmaceutical companies New life sciences executive brings more than 25 years of leg
Achieve: Expedited Review Of Cytisinicline Sets The Stage For Development Expansion
07:15am, Monday, 20'th Oct 2025
Achieve Life Sciences maintains its 'Buy' rating as the FDA accepts the NDA for cytisinicline for smoking cessation, with a PDUFA date set for June 20, 2026. ACHV's expansion into e-cigarette and vapi
Potential First-in-Class Treatment for Nicotine E-cigarette or Vaping Cessation Receives Unprecedented Expedited Review Pathway
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
04:01pm, Thursday, 02'nd Oct 2025
SEATTLE and VANCOUVER, British Columbia, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development a
New data address critical treatment gap for millions of Americans with COPD who face unique smoking cessation challenges New data address critical treatment gap for millions of Americans with COPD who
Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer
08:30am, Thursday, 18'th Sep 2025
Donnelly brings more than 25 years of biopharmaceutical expertise in CMC and regulatory operations Donnelly brings more than 25 years of biopharmaceutical expertise in CMC and regulatory operations
